The economic burden of fracture patients with osteoporosis in western China

The economic burden of fracture patients with osteoporosis in western China
复制标题

DOI:
10.1007/s00198-014-2699-0
复制
发表时间:
2014-07-01
影响因子:
4
通讯作者:
Hong, Z.
Hong, Z.
中科院分区:
医学2区
文献类型:
--
作者:
Qu, B.;Ma, Y.;Hong, Z.

文献摘要

被引文献

相似文献

为了研究中国骨折的费用,我们进行了一项前瞻性研究,比较了三个最常见部位骨折的转诊患者的疾病费用。我们的研究结果表明,腰椎骨折对中国患者和国家的经济负担都很重。本文旨在研究中国腰椎骨折的费用,从而提供有关该疾病对个人和社会负担的必要信息。这项前瞻性观察性数据收集研究评估了与髋关节,椎骨,和骨折后1年的腕部骨折,基于由938名男性和女性组成的患者样本。通过患者记录、登记来源和患者访谈收集信息。直接医疗、直接非医疗、间接非医疗费用均以髋部骨折患者的年总费用最高(人民币,27,283元或4,330美元,置信区间(257152851元)),其次为椎体骨折患者(21,474元或3,409美元,置信区间为2008222866元)和手腕骨折(8,828元或1,401美元,置信区间为78299827元)。平均每位患者每年的直接医疗费用约为人民币17,007元,其中住院费用、药品和检查费用占大部分。非医疗直接费用远低于直接医疗费用,平均约为人民币1,846元。这些结果表明,中国骨折患者和中国的经济负担都很重,中国的费用比例与其他国家相比具有许多相似的特点,但也存在一些显著差异。
To study the cost of osteoporotic fracture in China, we performed a prospective study and compared the costs of the disease in referral patients with fractures in three of the most common sites. Our results indicated that the economic burden of osteoporotic fracture to both Chinese patients and the nation is heavy.This paper aims to study the cost of osteoporotic fracture in China and thus to provide essential information about the burden of this disease to individuals and society.This prospective observational data collection study assessed the cost related to hip, vertebral, and wrist fracture 1 year after the fracture based on a patient sample consisting of 938 men and women. Information was collected using patient records, registry sources, and patient interviews. Both direct medical, direct non-medical, and indirect non-medical costs were considered.The annual total costs were highest in hip fracture patients (renminbi, RMB 27,283 or USD 4,330, with confidence interval (RMB 25715, 28851)), followed by patients with vertebral fracture (RMB 21,474 or USD 3,409, with confidence interval (RMB 20082, 22866)) and wrist fracture (RMB 8,828 or USD 1,401, with confidence interval (RMB 7829, 9827)). The direct medical care costs averaged approximately RMB 17,007 per year per patient, of which inpatient costs, drugs, and investigations accounted for the majority of the costs. Nonmedical direct costs were much less compared to direct healthcare costs and averaged approximately RMB 1,846.These results indicate that the economic burden of osteoporotic fracture to both Chinese patients and China was heavy, and the proportion of the costs in China demonstrated many similar features and some significant differences compared to other countries.